Ignite Creation Date:
2024-05-05 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00730522
Status:
TERMINATED
Last Update Posted:
2020-12-09
First Post:
2008-08-05
Brief Title:
Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
Sponsor:
Catalyst Pharmaceuticals Inc
Organization:
Catalyst Pharmaceuticals Inc
Organization Data
Organization:
Catalyst Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CPP-02001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Catalyst Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None